Valeant Pharmaceuticals International Inc (NYSE:VRX)

241.73
Delayed Data
As of 4:01pm ET
 +2.61 / +1.09%
Today’s Change
106.00
Today|||52-Week Range
246.01
+68.91%
Year-to-Date
Actavis' Viberzi Gets FDA Nod for Irritable Bowel Syndrome - Analyst Blog
6:13pm / Zacks.com
Calithera Biosciences (CALA) in Focus, Stock Rises 10.8% - Tale of the Tape
May 22 / Zacks.com
Valeant Pharmaceuticals Gets FDA Nod for Xifaxan for IBS-D - Analyst Blog
3:13pm / Zacks.com
Synergy Pharmaceuticals (SGYP) Jumps: Stock Rises 7.3% - Tale of the Tape
May 22 / Zacks.com
GlobeImmune-Gilead's Hepatitis B Drug Fails in Phase II - Analyst Blog
3:13pm / Zacks.com
6 stocks to buy...according to hedge funds
May 21 / CNNMoney.com
Insider Trading Alert - NMRX, AMNB And VRX Traded By Insiders
11:27am / TheStreet.com
Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? - Tale of the Tape
May 20 / Zacks.com
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's New Lifetime High...
9:58am / TheStreet.com
Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog
May 19 / Zacks.com
It's Official: Avago Buys Broadcom In $37 Billion Deal, Thousands In Employee Layoff ...
8:47am / Investing Channel
Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog
May 19 / Zacks.com
Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog
May 27 / Zacks.com
Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog
May 19 / Zacks.com
3 Drug Stocks Prescribed for Portfolio Growth - Analyst Blog
May 27 / Zacks.com
Endo International (ENDP) Expands Generics with $8 Billion Par Pharma Buy - Stocks i...
May 18 / Zacks.com
Merck KGaA-BioMarin's Kuvan may Undergo Label Update - Analyst Blog
May 27 / Zacks.com
Immunomedics' Drug Gets Fast Track Status for Lung Cancer - Analyst Blog
May 18 / Zacks.com
Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog
May 27 / Zacks.com
Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog
May 18 / Zacks.com
Pharmacyclics' Imbruvica Gets CHMP's Nod for Full Approval - Analyst Blog
May 26 / Zacks.com
AstraZeneca Reports Data from KODIAC studies on Movantik - Analyst Blog
May 18 / Zacks.com
Here's What Bill Ackman Has Been Buying and Selling
May 26 / MotleyFool.com
Astellas' Myrbetriq for Overactive Bladder Efficient as Add-On - Analyst Blog
May 18 / Zacks.com
Merck KGaA-BioMarin's Kuvan may Undergo Label Update - Analyst Blog
May 26 / Zacks.com
Amgen Announces Positive Results on Migraine Candidate - Analyst Blog
May 15 / Zacks.com
Bristol-Myers' Opdivo Gets Positive Opinion from CHMP - Analyst Blog
May 25 / Zacks.com
Corcept Therapeutics' Korlym Positive in Breast Cancer Study - Analyst Blog
May 15 / Zacks.com
Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog
May 25 / Zacks.com
Heron Therapeutics' HTX-019 Meeting with FDA Successful - Analyst Blog
May 15 / Zacks.com
Billionaire George Soros Just Sold These 3 Stocks: Should You?
May 23 / MotleyFool.com
GlycoMimetics' Leukemia Drug Gets Orphan Status in U.S. - Analyst Blog
May 15 / Zacks.com
Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog
May 22 / Zacks.com
Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog
May 15 / Zacks.com
Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog
May 22 / Zacks.com
4 stock tips from Wall Street's star managers
May 05 / CNNMoney.com
Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog
May 22 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account